VIVO
Meridian Bioscience Inc
Price:  
33.97 
USD
Volume:  
2,039,919.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIVO WACC - Weighted Average Cost of Capital

The WACC of Meridian Bioscience Inc (VIVO) is 8.8%.

The Cost of Equity of Meridian Bioscience Inc (VIVO) is 8.90%.
The Cost of Debt of Meridian Bioscience Inc (VIVO) is 4.25%.

Range Selected
Cost of equity 7.30% - 10.50% 8.90%
Tax rate 22.00% - 22.40% 22.20%
Cost of debt 4.00% - 4.50% 4.25%
WACC 7.2% - 10.3% 8.8%
WACC

VIVO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.74 1
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 10.50%
Tax rate 22.00% 22.40%
Debt/Equity ratio 0.02 0.02
Cost of debt 4.00% 4.50%
After-tax WACC 7.2% 10.3%
Selected WACC 8.8%